The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Advisories
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Advisories
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Advisories
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Letters/Comments
An announcement of the Final Rule issued by the IRS.
Magazine & Journal Articles
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.